Skip to content
Blue Works World

Administering Pluripotent Cells in Utero to Babies with Neural Tube Defect Improves Quality of Life, Study Reveals

An innovative research effort has revealed that administering stem cells to developing infants affected by spina bifida during corrective surgery can be a "major milestone" in treating birth defects.

Trial Details and Safety

The US-based trial focused on six fetuses with a severe neural tube defect. Medical teams placed mother's placental stem cells directly onto the developing neural column while the defect was being closed.

Importantly, the stem cell application demonstrated a favorable safety profile. The study team reported that the treatment did not lead to tumors, hinder surgical recovery, or prevent the reversal of related neurological issues.

Positive Developments

Imaging conducted after delivery indicated a complete reversal of brainstem displacement in all six infants. This brain structure normalization is a key indicator for enhanced physical outcomes.

"Should it enable additional babies able to walk who previously could not, it could establish itself as the conventional approach," said the lead researcher. "The outcomes appear profoundly encouraging and create a pathway toward numerous possible new treatments."

Long-Term Prospects and Optimism

Experts not involved in the trial indicated that subsequent studies of these apparent benefits could herald a "new era" in fetal surgery. The possibility of ameliorating neural deficits present before birth is considered a transformative goal.

Notably important would be improvements in urogenital and gastrointestinal outcomes, which are common challenges for individuals living with this defect.

Looking Ahead

Despite this being a first-in-human effort was small in scale, its established security and encouraging indicators provide a strong foundation for broader investigative efforts. The addition of cellular treatment with established fetal surgery techniques holds considerable promise for transforming outcomes for future generations with myelomeningocele.

By

Stacy Lee

Liam van der Meer is a freelance writer and editor passionate about tech and culture, based in Amsterdam.

Blue Works World

Type to search articles.